Insider Transactions in Q4 2021 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 15
2021
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
34
-0.05%
|
$6,358
$187.15 P/Share
|
Nov 15
2021
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
3
-0.0%
|
$561
$187.4 P/Share
|
Nov 15
2021
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
51
-0.08%
|
$9,537
$187.13 P/Share
|
Nov 01
2021
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
766
-2.3%
|
$141,710
$185.07 P/Share
|